These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. Das S; Ng WK; Kanaujia P; Kim S; Tan RB Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615 [TBL] [Abstract][Full Text] [Related]
3. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
4. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles. Das S; Ng WK; Tan RB Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790 [TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil. Shi F; Zhao JH; Liu Y; Wang Z; Zhang YT; Feng NP Int J Nanomedicine; 2012; 7():2033-43. PubMed ID: 22619540 [TBL] [Abstract][Full Text] [Related]
6. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
8. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method. Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624 [TBL] [Abstract][Full Text] [Related]
9. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990 [TBL] [Abstract][Full Text] [Related]
10. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
11. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model. Shi LL; Cao Y; Zhu XY; Cui JH; Cao QR Int J Pharm; 2015 Jan; 478(1):60-69. PubMed ID: 25448568 [TBL] [Abstract][Full Text] [Related]
12. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. Vivek K; Reddy H; Murthy RS AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544 [TBL] [Abstract][Full Text] [Related]
13. A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid. Fàbregas A; Sánchez-Hernández N; Ticó JR; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Hernández-Munain C; Suñé C; Miñarro M Int J Pharm; 2014 Oct; 473(1-2):270-9. PubMed ID: 24999055 [TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation. Rajpoot K; Jain SK Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1236-1247. PubMed ID: 28849671 [TBL] [Abstract][Full Text] [Related]
15. Acyclovir Solid Lipid Nanoparticles for Skin Drug Delivery: Fabrication, Characterization and In vitro Study. Bhupinder K; Newton MJ Recent Pat Drug Deliv Formul; 2017; 11(2):132-146. PubMed ID: 28124592 [TBL] [Abstract][Full Text] [Related]
16. Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line. Campos JR; Fernandes AR; Sousa R; Fangueiro JF; Boonme P; Garcia ML; Silva AM; Naveros BC; Souto EB Pharm Dev Technol; 2019 Jun; 24(5):616-622. PubMed ID: 30477410 [TBL] [Abstract][Full Text] [Related]
17. Preparation and Optimization of Meropenem-Loaded Solid Lipid Nanoparticles: In Vitro Evaluation and Molecular Modeling. Mhango EKG; Kalhapure RS; Jadhav M; Sonawane SJ; Mocktar C; Vepuri S; Soliman M; Govender T AAPS PharmSciTech; 2017 Aug; 18(6):2011-2025. PubMed ID: 27933586 [TBL] [Abstract][Full Text] [Related]
18. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546 [TBL] [Abstract][Full Text] [Related]
19. Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles. Kalhapure RS; Mocktar C; Sikwal DR; Sonawane SJ; Kathiravan MK; Skelton A; Govender T Colloids Surf B Biointerfaces; 2014 May; 117():303-11. PubMed ID: 24667076 [TBL] [Abstract][Full Text] [Related]
20. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles. Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]